These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17667736)

  • 1. The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial.
    Steinglass J; Sysko R; Schebendach J; Broft A; Strober M; Walsh BT
    J Psychiatr Pract; 2007 Jul; 13(4):238-45. PubMed ID: 17667736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
    Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
    J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
    Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
    Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
    Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
    J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
    Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
    Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivational change in an inpatient anorexia nervosa population and implications for treatment.
    Wade TD; Frayne A; Edwards SA; Robertson T; Gilchrist P
    Aust N Z J Psychiatry; 2009 Mar; 43(3):235-43. PubMed ID: 19221912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
    Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
    Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
    Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
    J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming fear of eating: A case study of a novel use of exposure and response prevention.
    Glasofer DR; Albano AM; Simpson HB; Steinglass JE
    Psychotherapy (Chic); 2016 Jun; 53(2):223-31. PubMed ID: 27267508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confronting fear using exposure and response prevention for anorexia nervosa: A randomized controlled pilot study.
    Steinglass JE; Albano AM; Simpson HB; Wang Y; Zou J; Attia E; Walsh BT
    Int J Eat Disord; 2014 Mar; 47(2):174-80. PubMed ID: 24488838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
    Guastella AJ; Richardson R; Lovibond PF; Rapee RM; Gaston JE; Mitchell P; Dadds MR
    Biol Psychiatry; 2008 Mar; 63(6):544-9. PubMed ID: 18179785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
    Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing exposure-based therapy from a translational research perspective.
    Hofmann SG
    Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.